Manage your personalised Watchlist.Set up an online Virtual Portfolio.Participate in Share Chat.See more trades and director dealings.Play the Fantasy Share Trading Game.
Register for FREE Now
We would love to hear your thoughts about our site and services, please take our survey here.
Timster
Posted in: AVCT
Posts: 19,014
Price: 48.25
No Opinion
SMDC were supposed to be reviewing the data end of April will be interesting next week. Although it will just be a recommendation to up the dose and continue I'd imagine.
Price: 44.75
i hope episode 3 has eggy and touk from the fud department talking ****e.
Price: 44.50
1. AVA6000 exhibited rapid distribution, with a half-life of 45 minutes backing up my assertion that dilution in the bloodstream is too rapid. Comedy gold 😂😂😂😂😂
You'll be sorry when it's £20 in a few weeks doggy
When I when will the death spiral end ☠️
Wonder if AS has a short, he's made those guys a lot of money 🤬
Price: 48.00
Sheppy still finds time to be miserable on his (fantasy) holiday in the Maldives.
Price: 49.75
And so the circle of fud continues https://wondermark.com/c/1062/
You could try clinicaltrials@avacta.com https://avacta.com/clinical-trials/
It's wynbore ffs what do you expect.
Wonder if they'll send a new team of fudsters into the wild. Can't wait....
Price: 50.00
Enjoying the Maldives sheppy?
Price: 50.75
Don't know why you bother, it's a death spiral, we're doomed ☠️
Even if they do get rid of DX they will keep affimers. Will just be as before designing affimer for clients like with affyxcell. And one of the new pre|CISION products also utilises affimer. On a side note does that mean TMAC shelved?
Outrageous, even the finest troll twat isn't worth £10 a post. As PL75 says these are exceptional twats but come on....!
Price: 51.00
Worth remembering sujood is never wrong.
Price: 51.50
Interesting to note that you're still a twat.
"remember phase 1 was all about efficacy" Did you mean NOT. It's just safety and tolerability. So the efficacy seen is pretty amazing.
That's what I meant and what we've been told is end of April.
3rd patient will receive their 3rd dose this week. The other 2 may have had it already. Few weeks for the safety committee to review this cohort.
Login failed